AN

Healthcare · Pharmaceuticals

Anuh Pharma Ltd (ANUHPHR)

₹79.28

Mkt cap
₹810 Cr
P/E ratio
17.00
P/B
2.21
Div yield
1.86%
ROE
11.30%
ROCE
14.90%
EPS (TTM)
₹4.66
Book value
₹36
52W range
67–100
Sector
Healthcare

Price history

Previous close

Incorporated in 1960, Anuh Pharma Ltd is in the business of manufacturing and selling of Bulk drugs and chemicals [1]

NSE ANUHPHRBSE 506260
Health check
Constructive
ValuationCheap
ProfitabilityAverage
GrowthModerate
TechnicalsNeutral
52-week range
−20.32% from high
₹79
₹67+18.33% from low₹100
Current
₹79.28
Prev close
₹79.76
Day
−0.60%
Price performance
1D
−0.85%
1W
−4.09%
1M
+0.27%
3M
+4.18%
6M
+3.82%
1Y
−2.67%
YTD
−1.15%

Financials

Revenue, profit & margin
P/E ratio
17.0×
ANUHPHR is 49% below the sector median of 33.4×
ANUHPHR17.0×
Sector median33.4×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales150172164138166160198186186197202194185
YoY Sales growth+30%+24%+4%-15%+11%-7%+21%+35%+12%+24%+2%+4%-0%
Expenses132148145127149145179176174178182178168
Operating Profit18241911171519101219201617
OPM %12%14%12%8%10%9%9%6%6%10%10%8%9%
Other Income2434311312-131
Interest0000000000000
Depreciation2222223333322
Profit before tax18252012181317111018161715
Tax %23%24%22%22%17%22%28%24%23%25%25%32%25%
Net Profit141915101510128813121111
EPS in Rs1.381.911.530.951.501.031.240.830.761.341.171.141.12
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −2.63% · closed higher next day 0 of last 2
 Q1FY27†Q2FY27
Broadcast7 Aug '26◦30 Oct '26◦
Earnings day−2.12%−3.15%
+1 day−1.97%−7.06%
+5 days−4.54%−5.19%
+15 days+3.43%—
+30 days+17.85%—
FilingPDFXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
71.79%Promoter
Promoters71.79%
FIIs0.11%0.10
DIIs0.00%
Public28.07%0.12
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,870.0036.464,48,6760.86%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,150.0086.622,95,9970.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,668.8081.801,77,5860.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,338.0094.281,26,3250.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,204.2026.511,20,1190.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,388.0041.411,15,9360.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,388.0036.111,12,1350.94%852−35.05%7,404−2.44%15.49%
Anuh Pharma₹80.7716.958101.86%11+47.31%185−0.34%14.94%
Median: 160 Co.₹445.7333.352,0160.08%13+33.73%179+21.23%14.94%

Filings